Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 15, 2015 - Issue 11
Submit an article Journal homepage
481
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Asian perspectives on the recognition and management of levodopa ‘wearing-off’ in Parkinson’s disease

Roongroj BhidayasiriChulalongkorn Centre of Excellence for Parkinson’s Disease & Related Disorders, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, ThailandCorrespondence[email protected]
,
Nobutaka HattoriJuntendo University School of Medicine, Tokyo, Japan
,
Beomseok JeonSeoul National University, Seoul, South Korea
,
Rou-Shayn ChenChang Gung Memorial Hospital, Lingkou, Taiwan
,
Moon Keen LeeSunway Medical Centre, Jalan Lagoon Selatan, Bandar Sunway, 46150 Petaling Jaya, Selangor, Malaysia
,
Jawad A BajwaNational Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia
,
Vincent CT MokDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China
,
Baorong ZhangDepartment of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
,
Thamrin SyamsudinNational Brain Centre Hospital, Jakarta, Indonesia
,
Louis Chew Seng TanNational Neuroscience Institute, 11 Jalan Tan Tock Seng, Singapore
,
Roland Dominic G JamoraDepartment of Neurosciences, College of Medicine-Philippine General Hospital, University of the Philippines Manila, Manila, Philippines;Movement Disorder Service and Section of Neurology, Institute for Neurosciences, St. Luke’s Medical Center-Quezon City and Global City, Philippines
,
Apichart PisarnpongDepartment of Neurology, Bangkok Hospital, Bangkok, Thailand
&
Werner PoeweInnsbruck Medical University, Innsbruck, Austria
 show all
Pages 1285-1297 | Published online: 21 Sep 2015

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Roongroj Bhidayasiri, Onanong Phokaewvarangkul, Karn Sakdisornchai, Kamolwan Boonpang, K. Ray Chaudhuri, Jan Parsons, Praween Lolekha, Parnsiri Chairangsaris, Prachaya Srivanitchapoom, Sharon Benedierks, Pattamon Panyakaew, Thanatat Boonmongkol, Yuwadee Thongchuam, Nitinan Kantachadvanich, Saisamorn Phumphid, Andrew H. Evans, Akravudh Viriyavejakul, Apichart Pisarnpong, Teus van Laar & Priya Jagota. (2020) Establishing apomorphine treatment in Thailand: understanding the challenges and opportunities of Parkinson’s disease management in developing countries. Expert Review of Neurotherapeutics 20:6, pages 523-537.
Read now

Articles from other publishers (21)

Gregory M. Pontone, Bradley McDaniels, Adrienne M Keener & Indu Subramanian. (2023) A Wellness Prescription for Parkinson's: Mid to Late-Stage Disease. The American Journal of Geriatric Psychiatry 31:9, pages 737-747.
Crossref
Roongroj Bhidayasiri, Jirada Sringean, Tuan Van Le, Thien Thien Lim, Chum Navuth, Appasone Phoumindr, Yin Minn Aye, Saisamorn Phumphid, Somchit Vorachit, Keo Veasna, Norlinah Mohamed Ibrahim, Win Min Thit, Raymond L. Rosales, Minh Le & Ngoc Tai Tran. (2023) Movement disorders in Indochina: Resource challenges and future solutions. Journal of Neural Transmission 130:7, pages 875-889.
Crossref
Roongroj Bhidayasiri, Takayuki Ishida, Takanori Kamei, Ryan Edbert Husni, Ippei Suzuki, Shey Lin Wu & Jin Whan Cho. (2023) Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson’s Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study. Journal of Movement Disorders 16:2, pages 180-190.
Crossref
Amnon A. Berger, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Jessica S. Kaye, Rachel J. Kaye, Elisa E. Neuchat, Adam M. Kaye, Edward S. Alpaugh, Elyse M. Cornett, Andrew H. Han & Alan D. Kaye. (2022) Opicapone, a Novel Catechol-O-methyl Transferase Inhibitor, for Treatment of Parkinson’s Disease “Off” Episodes. Health Psychology Research 10:5.
Crossref
Amnon A. Berger, Christopher Robinson, Ariel Winnick, Jonathan Izygon, Binil M. Jacob, Mackenzie J. Noonan, Alan D. Kaye, Jessica S. Kaye, Adam M. Kaye, Elyse M. Cornett, Rutvij J. Shah, Omar Viswanath & Ivan Urits. (2021) Opicapone for the Treatment of Parkinson’s Disease "Off" Episodes: Pharmacology and Clinical Considerations. Clinical Drug Investigation 42:2, pages 127-135.
Crossref
Roongroj Bhidayasiri, Sasivimol Virameteekul, Banon Sukoandari, Tai Ngoc Tran & Thien Thien Lim. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1061 1081 .
Ramón Cacabelos, Iván Carrera, Olaia Martínez, Ramón Alejo, Lucía Fernández‐Novoa, Pablo Cacabelos, Lola Corzo, Susana Rodríguez, Margarita Alcaraz, Laura Nebril, Iván Tellado, Natalia Cacabelos, Rocío Pego, Vinogran Naidoo & Juan C. Carril. (2021) Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Medicinal Research Reviews 41:5, pages 2841-2886.
Crossref
Dongwoo Chae, Su Jin Chung, Phil Hyu Lee & Kyungsoo Park. (2021) Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale. CPT: Pharmacometrics & Systems Pharmacology 10:6, pages 611-621.
Crossref
Diana-Lynn S. Que & Roland Dominic G. Jamora. (2021) Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review. Clinical Therapeutics 43:1, pages e19-e31.
Crossref
Roongroj Bhidayasiri, Sasivimol Virameteekul, Banon Sukoandari, Tai Ngoc Tran & Thien Thien Lim. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 21 .
Chao Han, Wei Mao, Jing An, Lifei Jiao & Piu Chan. (2020) Early morning off in patients with Parkinson’s disease: a Chinese nationwide study and a 7-question screening scale. Translational Neurodegeneration 9:1.
Crossref
Onanong Phokaewvarangkul, Somchit Vorachit, Appasone Phoumindr, Saysavath Keosodsay, Ronald B. Postuma, Wassilios G. Meissner & Roongroj Bhidayasiri. (2020) Addressing knowledge gaps in Parkinson’s disease: a report on the Movement Disorder Society’s Centre-to-Centre initiative to improve Parkinson’s disease services in Lao People’s Democratic Republic. BMC Medical Education 20:1.
Crossref
Baihua Sun, Tao Wang, Nianying Li & Jin Qiao. (2020) Analysis of Motor Complication and Relative Factors in a Cohort of Chinese Patients with Parkinson’s Disease. Parkinson's Disease 2020, pages 1-7.
Crossref
Shen-Yang Lim, Ai Huey Tan, Azlina Ahmad-Annuar, Christine Klein, Louis C S Tan, Raymond L Rosales, Roongroj Bhidayasiri, Yih-Ru Wu, Hui-Fang Shang, Andrew H Evans, Pramod K Pal, Nobutaka Hattori, Chong Tin Tan, Beomseok Jeon, Eng-King Tan & Anthony E Lang. (2019) Parkinson's disease in the Western Pacific Region. The Lancet Neurology 18:9, pages 865-879.
Crossref
Sachiko Kasamo, Masato Takeuchi, Masashi Ikuno, Yohei Kawasaki, Shiro Tanaka, Ryosuke Takahashi & Koji Kawakami. (2019) Real-world pharmacological treatment patterns of patients with young-onset Parkinson’s disease in Japan: a medical claims database analysis. Journal of Neurology 266:8, pages 1944-1952.
Crossref
Nobutaka Hattori, Atsushi Takeda, Shinichi Takeda, Akira Nishimura, Ryou Nakaya, Hideki Mochizuki, Masahiro Nagai & Ryosuke Takahashi. (2019) Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease. Journal of Neural Transmission 126:3, pages 289-297.
Crossref
Ramón Cacabelos, Pablo Cacabelos & Juan C. Carril. 2019. Pharmacoepigenetics. Pharmacoepigenetics 903 950 .
Miho Murata, Masahito Mihara, Kazuko Hasegawa, Beomseok Jeon, Chon-Haw Tsai, Noriko Nishikawa, Tomoko Oeda, Masayuki Yokoyama, Weining Z. Robieson, Krai Chatamra, Maurizio F. Facheris & Janet Benesh. (2018) Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease. Therapeutic Advances in Neurological Disorders 11, pages 175628641875931.
Crossref
Roland Dominic G Jamora & Janis M Miyasaki. (2017) Treatment gaps in Parkinson’s disease care in the Philippines. Neurodegenerative Disease Management 7:4, pages 245-251.
Crossref
Ramón Cacabelos. (2017) Parkinson’s Disease: From Pathogenesis to Pharmacogenomics. International Journal of Molecular Sciences 18:3, pages 551.
Crossref
Anna Sauerbier, Onanong Jitkritsadakul, Nataliya Titova, Lisa Klingelhoefer, Yoshio Tsuboi, Harry Carr, Hrishikesh Kumar, Rebecca Banerjee, Roberto Erro, Roongroj Bhidayasiri, Anette Schrag, Panagiotis Zis, Shen-Yang Lim, J.Y. Al-Hashel, Walaa A. Kamel, Pablo Martinez-Martin & K. Ray Chaudhuri. (2017) Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations. Neuroepidemiology 49:1-2, pages 1-17.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.